INSIGHT of Medicine(phase 7,2024)

1.Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world studyFollowing the approval of Arzuphin a

Insight Medicine February 27,2024

INSIGHT of Medicine(phase 7,2024)

1.Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world studyFollowing the approval of Arzuphin a

Insight Medicine February 27,2024

Two Alzheimer's risk genes linked to brain atrophy, promise future blood markers

by Indiana UniversityA depiction of the double helical structure of DNA. Its four coding units (A, T, C, G) are color-coded in pink, orange, purple and yellow. Credit: NHGRITwo genetic variants p

Neurology February 27,2024

Two Alzheimer's risk genes linked to brain atrophy, promise future blood markers

by Indiana UniversityA depiction of the double helical structure of DNA. Its four coding units (A, T, C, G) are color-coded in pink, orange, purple and yellow. Credit: NHGRITwo genetic variants p

Neurology February 27,2024

Genes that may protect against dementia

by Ricki Lewis, Phd,Public Library of Science"Survival of the fittest" is one of the most misunderstood terms in biology. Evoking images of physical prowess, it actually refers to an i

Neurology February 27,2024

Genes that may protect against dementia

by Ricki Lewis, Phd,Public Library of Science"Survival of the fittest" is one of the most misunderstood terms in biology. Evoking images of physical prowess, it actually refers to an i

Neurology February 27,2024

The freedom to roam for people with dementia

by Andrew Gould,University of PlymouthIan Sherriff, centre, with members of the Dartmoor Search and Rescue Team Plymouth, at a recent trial of the technology on DartmoorThe debilitating effect o

Neurology February 27,2024

The freedom to roam for people with dementia

by Andrew Gould,University of PlymouthIan Sherriff, centre, with members of the Dartmoor Search and Rescue Team Plymouth, at a recent trial of the technology on DartmoorThe debilitating effect o

Neurology February 27,2024

Mesh-like scaffold is disordered in Alzheimer's-affected cells

by Will Sansom,University of Texas Health Science Center at San AntonioBrain cells from a fruit fly model of Alzheimer's disease were compared to healthy brain cells to show a type of dysfun

Neurology February 27,2024

Mesh-like scaffold is disordered in Alzheimer's-affected cells

by Will Sansom,University of Texas Health Science Center at San AntonioBrain cells from a fruit fly model of Alzheimer's disease were compared to healthy brain cells to show a type of dysfun

Neurology February 27,2024

Neuroscientists gain insight into cause of Alzheimer's symptoms

by Virginia TechVirginia Tech Carilion Research Institute scientists have uncovered a mechanism in the brain that could account for some of the neural degeneration and memory loss in people with

Neurology February 27,2024

Neuroscientists gain insight into cause of Alzheimer's symptoms

by Virginia TechVirginia Tech Carilion Research Institute scientists have uncovered a mechanism in the brain that could account for some of the neural degeneration and memory loss in people with

Neurology February 27,2024

People with dementia face discrimination and social rejection

by Nicole Bodnar,University of Toronto“People with dementia face discrimination and social rejection,” says Professor Pia Kontos, who spent most of her career challenging perceptions of dementia

Neurology February 27,2024

People with dementia face discrimination and social rejection

by Nicole Bodnar,University of Toronto“People with dementia face discrimination and social rejection,” says Professor Pia Kontos, who spent most of her career challenging perceptions of dementia

Neurology February 27,2024

Discovery adds context to Alzheimer's fight

by Paul Mayne,University of Western OntarioRobarts Research Institute scientists Vania and Marco Prado have found a gene, TRPM2, that could be a therapeutic target to assist in decreasing cognit

Neurology February 27,2024

Discovery adds context to Alzheimer's fight

by Paul Mayne,University of Western OntarioRobarts Research Institute scientists Vania and Marco Prado have found a gene, TRPM2, that could be a therapeutic target to assist in decreasing cognit

Neurology February 27,2024

Immune booster drugs meant to kill tumors found to improve Alzheimer's symptoms in mice

by Bob Yirka , Medical XpressCredit: martha sexton/public domain(MedicalXpress)—A team of researchers working at the Weizmann Institute of Science in Israel has found that a type of drug meant to help

Neurology February 27,2024

Immune booster drugs meant to kill tumors found to improve Alzheimer's symptoms in mice

by Bob Yirka , Medical XpressCredit: martha sexton/public domain(MedicalXpress)—A team of researchers working at the Weizmann Institute of Science in Israel has found that a type of drug meant to help

Neurology February 27,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Neurology February 27,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Neurology February 27,2024